BioSpace News Archive

Dyadic International, Inc. announced its financial results for the second quarter of 2023, and highlighted recent company developments.

Cardiff Oncology, Inc. announced financial results for the second quarter ended June 30, 2023, and provided a business update.

Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 171,000 shares of its common stock to three employees outside Fusion’s 2020 Stock Option and Incentive Plan.

SWK Holdings Corporation, a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided a business update and announced its financial and operating results for the second quarter ended June 30, 2023.

DURECT Corporation announced financial results for the three months ended June 30, 2023 and provided a corporate update.

MorphoSys AG reports results for the second quarter and first half year of 2023.

Nephros, Inc., a leading water technology company providing filtration solutions to the medical and commercial markets, announced financial results for the second quarter ended June 30, 2023.

Maravai LifeSciences, Inc., a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of August.

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body, provided a business and financial update for the second quarter 2023.

Cardinal Health announced that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company’s capital surplus.